FDA NDC Directory · JSON-LD · Markdown
NDC 68788-8115 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION
| Labeler / Manufacturer | Preferred Pharmaceuticals Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA210534 |
| Dosage form / route | POWDER, FOR SUSPENSION · ORAL |
| Active ingredients | CEFDINIR (125 mg/5mL) |
| Marketing started | 20211207 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).